Schering To Fund Picovir Studies Under Development Deal With ViroPharma
Executive Summary
Schering-Plough will decide whether to fund additional development of ViroPharma's Picovir after assessing preclinical and Phase I data for an intranasal formulation of the common cold treatment in mid-2004